Free Trial
ASX:OSP

Osprey Medical (OSP) Stock Price, News & Analysis

Osprey Medical logo

About Osprey Medical Stock (ASX:OSP)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.25 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

Remove Ads
Receive OSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osprey Medical and its competitors with MarketBeat's FREE daily newsletter.

OSP Stock News Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints
See More Headlines

OSP Stock Analysis - Frequently Asked Questions

Osprey Medical, Inc. (ASX:OSP) issued its earnings results on Wednesday, August, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Osprey Medical investors own include Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO), DW8 (DW8) and Dacian Gold (DCN).

Company Calendar

Last Earnings
8/14/2019
Today
4/06/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:OSP
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.96 million
Price / Cash Flow
0.47
Book Value
A$0.20 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (ASX:OSP) was last updated on 4/6/2025 by MarketBeat.com Staff
From Our Partners